Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer

Zhao, Shuang G ; Bootsma, Matthew ; Zhou, Stanley ; Shrestha, Raunak ; Moreno-Rodriguez, Thaidy ; Lundberg, Arian ; Pan, Chu ; Arlidge, Christopher ; Hawley, James R and Foye, Adam , et al. (2024) In Nature Genetics 56(8). p.1689-1700
Abstract

The impact of variations in the three-dimensional structure of the genome has been recognized, but solid cancer tissue studies are limited. Here, we performed integrated deep Hi-C sequencing with matched whole-genome sequencing, whole-genome bisulfite sequencing, 5-hydroxymethylcytosine (5hmC) sequencing and RNA sequencing across a cohort of 80 biopsy samples from patients with metastatic castration-resistant prostate cancer. Dramatic differences were present in gene expression, 5-methylcytosine/5hmC methylation and in structural variation versus mutation rate between A and B (open and closed) chromatin compartments. A subset of tumors exhibited depleted regional chromatin contacts at the AR locus, linked to extrachromosomal circular... (More)

The impact of variations in the three-dimensional structure of the genome has been recognized, but solid cancer tissue studies are limited. Here, we performed integrated deep Hi-C sequencing with matched whole-genome sequencing, whole-genome bisulfite sequencing, 5-hydroxymethylcytosine (5hmC) sequencing and RNA sequencing across a cohort of 80 biopsy samples from patients with metastatic castration-resistant prostate cancer. Dramatic differences were present in gene expression, 5-methylcytosine/5hmC methylation and in structural variation versus mutation rate between A and B (open and closed) chromatin compartments. A subset of tumors exhibited depleted regional chromatin contacts at the AR locus, linked to extrachromosomal circular DNA (ecDNA) and worse response to AR signaling inhibitors. We also identified topological subtypes associated with stark differences in methylation structure, gene expression and prognosis. Our data suggested that DNA interactions may predispose to structural variant formation, exemplified by the recurrent TMPRSS2-ERG fusion. This comprehensive integrated sequencing effort represents a unique clinical tumor resource.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
author collaboration
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Humans, Male, DNA Methylation, 5-Methylcytosine/analogs & derivatives, Gene Expression Regulation, Neoplastic, Epigenomics/methods, Neoplasm Metastasis/genetics, Genome, Human, Prostatic Neoplasms/genetics, Epigenesis, Genetic, Receptors, Androgen/genetics, Chromatin/genetics, Prostatic Neoplasms, Castration-Resistant/genetics, Oncogene Proteins, Fusion/genetics, DNA/genetics, Whole Genome Sequencing, RNA/genetics, Prognosis
in
Nature Genetics
volume
56
issue
8
pages
1689 - 1700
publisher
Nature Publishing Group
external identifiers
  • pmid:39020220
  • scopus:85202476342
ISSN
1546-1718
DOI
10.1038/s41588-024-01826-3
language
English
LU publication?
no
additional info
© 2024. The Author(s).
id
a831c5d6-0b88-4ae2-bc23-18977d0c78b7
date added to LUP
2026-02-18 08:39:26
date last changed
2026-02-19 04:01:04
@article{a831c5d6-0b88-4ae2-bc23-18977d0c78b7,
  abstract     = {{<p>The impact of variations in the three-dimensional structure of the genome has been recognized, but solid cancer tissue studies are limited. Here, we performed integrated deep Hi-C sequencing with matched whole-genome sequencing, whole-genome bisulfite sequencing, 5-hydroxymethylcytosine (5hmC) sequencing and RNA sequencing across a cohort of 80 biopsy samples from patients with metastatic castration-resistant prostate cancer. Dramatic differences were present in gene expression, 5-methylcytosine/5hmC methylation and in structural variation versus mutation rate between A and B (open and closed) chromatin compartments. A subset of tumors exhibited depleted regional chromatin contacts at the AR locus, linked to extrachromosomal circular DNA (ecDNA) and worse response to AR signaling inhibitors. We also identified topological subtypes associated with stark differences in methylation structure, gene expression and prognosis. Our data suggested that DNA interactions may predispose to structural variant formation, exemplified by the recurrent TMPRSS2-ERG fusion. This comprehensive integrated sequencing effort represents a unique clinical tumor resource.</p>}},
  author       = {{Zhao, Shuang G and Bootsma, Matthew and Zhou, Stanley and Shrestha, Raunak and Moreno-Rodriguez, Thaidy and Lundberg, Arian and Pan, Chu and Arlidge, Christopher and Hawley, James R and Foye, Adam and Weinstein, Alana S and Sjöström, Martin and Zhang, Meng and Li, Haolong and Chesner, Lisa N and Rydzewski, Nicholas R and Helzer, Kyle T and Shi, Yue and Lynch, Molly and Dehm, Scott M and Lang, Joshua M and Alumkal, Joshi J and He, Hansen H and Wyatt, Alexander W and Aggarwal, Rahul and Zwart, Wilbert and Small, Eric J and Quigley, David A and Lupien, Mathieu and Feng, Felix Y}},
  issn         = {{1546-1718}},
  keywords     = {{Humans; Male; DNA Methylation; 5-Methylcytosine/analogs & derivatives; Gene Expression Regulation, Neoplastic; Epigenomics/methods; Neoplasm Metastasis/genetics; Genome, Human; Prostatic Neoplasms/genetics; Epigenesis, Genetic; Receptors, Androgen/genetics; Chromatin/genetics; Prostatic Neoplasms, Castration-Resistant/genetics; Oncogene Proteins, Fusion/genetics; DNA/genetics; Whole Genome Sequencing; RNA/genetics; Prognosis}},
  language     = {{eng}},
  number       = {{8}},
  pages        = {{1689--1700}},
  publisher    = {{Nature Publishing Group}},
  series       = {{Nature Genetics}},
  title        = {{Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer}},
  url          = {{http://dx.doi.org/10.1038/s41588-024-01826-3}},
  doi          = {{10.1038/s41588-024-01826-3}},
  volume       = {{56}},
  year         = {{2024}},
}